MPO and COVID-19: The above results are in accordance with a previous study performed in a different patient population of the same department, demonstrating that while immune stimulation (evaluated by myeloperoxidase) was significantly greater in COVID-19 patients compared to patients with H1N1 or bacterial sepsis, no difference was observed in coagulation factor levels between the different septic groups [13].